cjc-1295 ipamorelin clinical trial body composition CJC-1295/Ipamorelin for Women: GH Therapy After 35 CJC + Ipamorelin Peptide Therapy
Description
Patients with ER-positive tumors that expressed low levels of CDK10 , because of promoter methylation, relapsed early on tamoxifen treatment
Acta Paediatrica 2014;103(12):13016
In 2023, Lopez-Otin proposed twelve markers of aging, including genomic instability, telomere loss, epigenetic changes, loss of protein balance, failure of macroautophagy, dysregulated nutrient sensing, mitochondrial dysfunction, cell senescence, stem cell depletion, altered intercellular communication, chronic inflammation, and dysbiosis
doi:10.1002/1529-0131(200201)46:1 3.0.CO;2-H
A Hsct trial in stiff person syndrome: limited benefits halt enrollment but should be more to come
